Skip to main content

Table 2 Echocardiographic parameters and the blood pressure of the studied animals divided into study groups

From: Antioxidant defence and oxidative stress markers in cats with asymptomatic and symptomatic hypertrophic cardiomyopathy: a pilot study

Variable

HCM

SUB-HCM

Control

p value

total number

8

11

11

LA/Ao

2.42 (1.42–4.53)Controls

1.6 (1.25–1.96)Controls

1.3 (0.88–1.48)HCM, SUB-HCM

.0001

LVIDd

14 (9–23.6)

12.8 (10.1–17.5)

13.9 (12.4–20.3)

.3

IVSd

6.9 (4.4–8.8)Controls

6.1 (3.9–7.5)Controls

4.2 (3–5.3)HCM, SUB-HCM

.0002

LVPWd

7.65 (4.9–8.3)Controls

5.8 (3.7–7.4)

4 (2.9–5.6)HCM

.0014

LVIDs

6.1 (2.2–12.8)

5.3 (3.6–9.1)

8.1 (5.4–11.3)

.07

IVSs

8.55 (5.8–10.2)

7.5 (5.7–9.3)

7 (5.3–9.3)

.36

LVPWs

9.95 (7.4–13.4)Controls

8.1 (6.4–10.5)

6.4 (5.1–9.6)HCM

.0012

LVOTO

4/8

4/11

0/11

.04

HR

203 (162–265)

222 (136–285)

214 (154–234)

.52

SAP [mmHg]

110 (95–136)SUB-HCM

139 (110–146)HCM

128 (90–150)

.03

  1. Data are presented as median (range). Abbreviations: LA/Ao left atrium to aorta ratio, LVIDd left ventricular inner diameter in diastole, IVSd intraventricular septum in diastole, LVOTO left ventricular outflow tract obstruction, HR heart rate, SAP systolic arterial pressure. M-Mode heart dimensions were measured in the subvalvular region